Ryan J. Watts
2019
In 2019, Ryan J. Watts earned a total compensation of $5M as President and Chief Executive Officer at Denali Therapeutics, a 17% decrease compared to previous year.
Compensation breakdown
| Bonus | $311,740 |
|---|---|
| Option Awards | $3,252,452 |
| Salary | $566,800 |
| Stock Awards | $838,168 |
| Other | $9,447 |
| Total | $4,978,607 |
Watts received $3.3M in option awards, accounting for 65% of the total pay in 2019.
Watts also received $311.7K in bonus, $566.8K in salary, $838.2K in stock awards and $9.4K in other compensation.
Rankings
In 2019, Ryan J. Watts' compensation ranked 2,207th out of 13,971 executives tracked by ExecPay. In other words, Watts earned more than 84.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,207 out of 13,971 | 84th |
Division Manufacturing | 801 out of 5,701 | 86th |
Major group Chemicals And Allied Products | 254 out of 2,200 | 89th |
Industry group Drugs | 205 out of 1,886 | 89th |
Industry Biological Products, Except Diagnostic Substances | 52 out of 389 | 87th |
Source: SEC filing on April 22, 2020.
Watts' colleagues
We found three more compensation records of executives who worked with Ryan J. Watts at Denali Therapeutics in 2019.
News
Denali Therapeutics CEO Ryan Watts' 2021 pay jumps 36% to $13M
April 19, 2022
Denali Therapeutics CEO Ryan Watts' 2020 pay jumps 87% to $9.3M
April 22, 2021
Denali Therapeutics CEO Ryan Watts' 2019 pay slips 17% to $5M
April 22, 2020
Denali Therapeutics CEO Ryan Watts' 2018 pay jumps 338% to $6M
April 18, 2019